CONCORDBIO / NSE / Biotechnology & Drugs
Concord Biotech
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High1,979.2
Target Low987.05
Target Mean2.25
Target Median56.25
Risk Metrics
Overall RiskHigh risk
Board Risk46.92
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Concord Biotech - Positive Breakout: These 14 stocks cross above their 200 DMAs The Economic Times
Enterprise value to EBIT forward of Concord Biotech Ltd. – NSE:CONCORDBIO TradingView
Concord Biotech files Business Responsibility and Sustainability Report for FY26 scanx.trade
Daily Brief Health Care: Concord Biotech Ltd, United Therapeutics, Artrya , Takeda Pharmaceutical and more Smartkarma
Daily Brief India: Pvr Inox, Concord Biotech Ltd, BlackBuck, WeWork India Management, Apple, TAC InfoSec, Ola and more Smartkarma
Concord Biotech: A Fermentation Leader's Setting Up for a Cleaner FY27 Smartkarma
Stock FAQs
What is the symbol and ISIN of Concord Biotech?
Concord Biotech has the symbol CONCORDBIO and ISIN - INE338H01029.
What is the current price of Concord Biotech?
Concord Biotech is currently trading at INR 1,304.70.
What are the year high and year low of Concord Biotech?
Concord Biotech has a year high of INR 1,979.20 and a year low of INR 987.05.
What is the market capitalization of Concord Biotech?
Concord Biotech has a market capitalization of INR 13,586.76 crore.
What is the P/E ratio of Concord Biotech?
Concord Biotech has a P/E ratio of 40.74.
What is the dividend yield of Concord Biotech?
Concord Biotech has a dividend yield of 0.58%.
How is the financial performance of Concord Biotech based on revenue, net income, and EPS?
Concord Biotech has revenue of INR 10,548.91 crore, net income of INR 2,609.06 crore, and EPS of INR 25.23.
What is the book value of Concord Biotech?
Concord Biotech has a book value of INR 192.80.
What is the debt-to-equity ratio of Concord Biotech?
Concord Biotech has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Concord Biotech?
Concord Biotech has a price-to-book ratio of 6.77 and a price-to-sales ratio of 1.29.
© SharekeyX | Rusaka Technologies 2024-2026